Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial: Novel biomarkers for anticancer therapy.
Wang T, Chen ZS, Shi C, Ouyang L, Xiao H. Wang T, et al. Among authors: ouyang l. Front Pharmacol. 2023 Jan 6;13:1109761. doi: 10.3389/fphar.2022.1109761. eCollection 2022. Front Pharmacol. 2023. PMID: 36686681 Free PMC article. No abstract available.
Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity.
Chen C, Wang T, Wu F, Huang W, He G, Ouyang L, Xiang M, Peng C, Jiang Q. Chen C, et al. Among authors: ouyang l. Drug Des Devel Ther. 2014 Sep 2;8:1195-210. doi: 10.2147/DDDT.S62921. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25214764 Free PMC article.
Recent progress in DNA methyltransferase inhibitors as anticancer agents.
Zhang Z, Wang G, Li Y, Lei D, Xiang J, Ouyang L, Wang Y, Yang J. Zhang Z, et al. Among authors: ouyang l. Front Pharmacol. 2022 Dec 16;13:1072651. doi: 10.3389/fphar.2022.1072651. eCollection 2022. Front Pharmacol. 2022. PMID: 37077808 Free PMC article. Review.
Discovery of Novel Dual-Target Inhibitor of Bromodomain-Containing Protein 4/Casein Kinase 2 Inducing Apoptosis and Autophagy-Associated Cell Death for Triple-Negative Breast Cancer Therapy.
Zhang J, Tang P, Zou L, Zhang J, Chen J, Yang C, He G, Liu B, Liu J, Chiang CM, Wang G, Ye T, Ouyang L. Zhang J, et al. Among authors: ouyang l. J Med Chem. 2021 Dec 23;64(24):18025-18053. doi: 10.1021/acs.jmedchem.1c01382. Epub 2021 Dec 15. J Med Chem. 2021. PMID: 34908415 Free PMC article.
1,307 results